For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241127:nRSa7445Na&default-theme=true
RNS Number : 7445N Optima Health PLC 27 November 2024
Optima Health plc
("Optima", the "Company", and, together with its subsidiaries, the "Group")
Notice of Half Year Results
LONDON, UK, 27 November 2024, Optima Health (AIM: OPT), the UK's leading
provider of technology enabled corporate health and wellbeing solutions, will
announce its Half Year Results for the six months ended 30 September 2024 on
Wednesday 11 December 2024.
Jonathan Thomas, Chief Executive Officer, and Heidi Giles, Chief Financial
Officer, will host an in-person briefing for analysts at 11:00am GMT on the
day of the results at 1 Moorgate, London, EC2R 6EA. There will also be a live
webcast and conference call with a Q&A session.
For more details or to attend the briefing, please contact
optimahealth@icrinc.com
Enquiries
Optima Health +44(0)3300085113
Jonathan Thomas, CEO media@OptimaHealth.co.uk
Heidi Giles, CFO
Nominated Adviser and Corporate Broker
Panmure Liberum Limited +44 (0)20 3100 2000
Emma Earl / Will Goode/ Mark Rogers
Rupert Dearden
UK Financial PR Adviser optimahealth@icrinc.com
ICR Consilium
Mary-Jane Elliott / Angela Gray / Chris Welsh
About Optima Health
Optima Health is the UK's leading provider of occupational health and
wellbeing services, directly influencing and improving people's lives for 25
years. Optima Health's incredible team of professionals quickly and
effectively encapsulate client's needs, supporting organisations of all shapes
and sizes. Through tailored solutions and innovative systems, Optima Health
offers unparalleled clinical expertise to its clients. These solutions ensure
that processes are simple and allow its clients to spend more time focusing on
their employees driving a healthy, high-performing workplace. For more
information visit www.optima health.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NORFLFSRLALRFIS